CA Stock MarketDetailed Quotes

MDNA Medicenna Therapeutics Corp

Watchlist
  • 2.030
  • -0.050-2.40%
15min DelayMarket Closed Sep 20 16:00 ET
155.16MMarket Cap-5342P/E (TTM)

Medicenna Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
20.31%35.63M
-49.45%16.98M
-49.45%16.98M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
49.91%40.01M
-Cash and cash equivalents
20.31%35.63M
-49.45%16.98M
-49.45%16.98M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
54.55%36.15M
139.73%40.01M
Total current assets
20.50%37.94M
-47.57%19.08M
-47.57%19.08M
-39.10%23.21M
-34.86%27.68M
56.84%31.49M
55.55%36.39M
55.55%36.39M
46.39%38.11M
41.61%42.5M
Non current assets
-Goodwill
-8.33%55K
-6.56%57K
-6.56%57K
-6.45%58K
-6.35%59K
-7.69%60K
-6.15%61K
-6.15%61K
-8.82%62K
-8.70%63K
-Other intangible assets
--9.86M
----
----
----
----
----
----
----
----
----
Regulatory assets
42.75%1.19M
36.14%1.16M
36.14%1.16M
125.14%403K
105.37%306K
788.30%835K
-34.63%855K
-34.63%855K
-70.36%179K
-65.35%149K
Total assets
--1.19M
36.14%1.16M
36.14%1.16M
----
----
----
-34.63%855K
-34.63%855K
----
----
Liabilities
Current liabilities
-accounts payable
--3.53M
28.01%2.07M
28.01%2.07M
----
----
----
-3.29%1.62M
-3.29%1.62M
----
----
-Total tax payable
686.98%11.12M
250.63%11.08M
250.63%11.08M
-68.72%613K
-89.29%611K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
Current accrued expenses
--490K
-63.67%793K
-63.67%793K
----
----
----
130.03%2.18M
130.03%2.18M
----
----
Current liabilities
24.47%4.02M
-24.66%2.86M
-24.66%2.86M
34.69%4.03M
25.81%3.7M
50.58%3.23M
44.98%3.8M
44.98%3.8M
27.14%2.99M
-45.92%2.94M
Non current liabilities
Non current accrued expenses
--28K
----
----
----
----
----
----
----
----
----
Derivative product liabilities
686.98%11.12M
250.63%11.08M
250.63%11.08M
-68.72%613K
-92.06%453K
--1.41M
--3.16M
--3.16M
--1.96M
--5.71M
Total non current liabilities
225.96%15.14M
100.33%13.94M
100.33%13.94M
-6.26%4.64M
-50.19%4.31M
116.39%4.65M
165.55%6.96M
165.55%6.96M
110.51%4.95M
59.16%8.64M
Shareholders'equity
Share capital
11.62%112.65M
0.00%100.92M
0.00%100.92M
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
-common stock
11.62%112.65M
0.00%100.92M
0.00%100.92M
0.00%100.92M
-0.05%100.92M
19.24%100.92M
20.62%100.92M
20.62%100.92M
20.76%100.92M
26.10%100.98M
Additional paid-in capital
6.73%10.44M
12.75%10.7M
12.75%10.7M
9.86%10.21M
14.68%10.05M
17.39%9.78M
19.68%9.49M
19.68%9.49M
20.74%9.29M
20.26%8.76M
Gains losses not affecting retained earnings
-56.76%16K
-66.67%19K
-66.67%19K
-70.15%40K
-81.25%30K
-65.74%37K
-66.67%57K
-66.67%57K
-37.96%134K
-27.27%160K
Total equity
20.54%38.03M
-47.50%19.13M
-47.50%19.13M
-39.05%23.27M
-34.81%27.74M
56.63%31.55M
55.38%36.45M
55.38%36.45M
46.22%38.17M
41.43%42.56M
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 20.31%35.63M-49.45%16.98M-49.45%16.98M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M49.91%40.01M
-Cash and cash equivalents 20.31%35.63M-49.45%16.98M-49.45%16.98M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M54.55%36.15M139.73%40.01M
Total current assets 20.50%37.94M-47.57%19.08M-47.57%19.08M-39.10%23.21M-34.86%27.68M56.84%31.49M55.55%36.39M55.55%36.39M46.39%38.11M41.61%42.5M
Non current assets
-Goodwill -8.33%55K-6.56%57K-6.56%57K-6.45%58K-6.35%59K-7.69%60K-6.15%61K-6.15%61K-8.82%62K-8.70%63K
-Other intangible assets --9.86M------------------------------------
Regulatory assets 42.75%1.19M36.14%1.16M36.14%1.16M125.14%403K105.37%306K788.30%835K-34.63%855K-34.63%855K-70.36%179K-65.35%149K
Total assets --1.19M36.14%1.16M36.14%1.16M-------------34.63%855K-34.63%855K--------
Liabilities
Current liabilities
-accounts payable --3.53M28.01%2.07M28.01%2.07M-------------3.29%1.62M-3.29%1.62M--------
-Total tax payable 686.98%11.12M250.63%11.08M250.63%11.08M-68.72%613K-89.29%611K--1.41M--3.16M--3.16M--1.96M--5.71M
Current accrued expenses --490K-63.67%793K-63.67%793K------------130.03%2.18M130.03%2.18M--------
Current liabilities 24.47%4.02M-24.66%2.86M-24.66%2.86M34.69%4.03M25.81%3.7M50.58%3.23M44.98%3.8M44.98%3.8M27.14%2.99M-45.92%2.94M
Non current liabilities
Non current accrued expenses --28K------------------------------------
Derivative product liabilities 686.98%11.12M250.63%11.08M250.63%11.08M-68.72%613K-92.06%453K--1.41M--3.16M--3.16M--1.96M--5.71M
Total non current liabilities 225.96%15.14M100.33%13.94M100.33%13.94M-6.26%4.64M-50.19%4.31M116.39%4.65M165.55%6.96M165.55%6.96M110.51%4.95M59.16%8.64M
Shareholders'equity
Share capital 11.62%112.65M0.00%100.92M0.00%100.92M0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M
-common stock 11.62%112.65M0.00%100.92M0.00%100.92M0.00%100.92M-0.05%100.92M19.24%100.92M20.62%100.92M20.62%100.92M20.76%100.92M26.10%100.98M
Additional paid-in capital 6.73%10.44M12.75%10.7M12.75%10.7M9.86%10.21M14.68%10.05M17.39%9.78M19.68%9.49M19.68%9.49M20.74%9.29M20.26%8.76M
Gains losses not affecting retained earnings -56.76%16K-66.67%19K-66.67%19K-70.15%40K-81.25%30K-65.74%37K-66.67%57K-66.67%57K-37.96%134K-27.27%160K
Total equity 20.54%38.03M-47.50%19.13M-47.50%19.13M-39.05%23.27M-34.81%27.74M56.63%31.55M55.38%36.45M55.38%36.45M46.22%38.17M41.43%42.56M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data